Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Toxicon : Official Journal of the International Society on Toxinology
|
October 20, 2025
Complying with ARRIVE 2.0: Reporting essentials for animal models of envenoming therapeutic efficacy testing
Amy E Marriott, Stuart Ainsworth
F1000Research
|
May 6, 2024
Improving <i>in vivo</i> assays in snake venom and antivenom research: A community discussion
Amy E Marriott, Nicholas R Casewell, Elliot Lilley, et al.
Veterinary Parasitology
|
March 4, 2020
Novel anti-Wolbachia drugs, a new approach in the treatment and prevention of veterinary filariasis?
Joseph D Turner, Amy E Marriott, David Hong, et al.
Scientific Reports
|
April 14, 2018
Validation of ultrasound bioimaging to predict worm burden and treatment efficacy in preclinical filariasis drug screening models
Amy E Marriott, Hanna Sjoberg, Hayley Tyrer, et al.
Plos Neglected Tropical Diseases
|
June 7, 2022
A mouse infection model and long-term lymphatic endothelium co-culture system to evaluate drugs against adult Brugia malayi
Amy E Marriott, Julio Furlong Silva, Nicolas Pionnier, et al.
The Journal of Clinical Investigation
|
January 12, 2021
Tetracyclines improve experimental lymphatic filariasis pathology by disrupting interleukin-4 receptor-mediated lymphangiogenesis
Julio Furlong-Silva, Stephen D Cross, Amy E Marriott, et al.
Plos Neglected Tropical Diseases
|
August 4, 2025
Preclinical evaluation of the neutralising efficacy of three antivenoms against the venoms of the recently taxonomically partitioned E. ocellatus and E. romani
Rebecca J Edge, Amy E Marriott, Molly Keen, et al.
Toxicon: X
|
March 24, 2022
<i>In vitro</i> and <i>in vivo</i> preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by <i>Dispholidus typus</i>
Stefanie K Menzies, Rachel H Clare, Chunfang Xie, et al.
Toxicon: X
|
September 16, 2024
Plug and play virus-like particles for the generation of anti-toxin antibodies
Rebecca J Edge, Amy E Marriott, Emma L Stars, et al.
Frontiers in Immunology
|
October 14, 2022
NKp46<sup>+</sup> natural killer cells develop an activated/memory-like phenotype and contribute to innate immunity against experimental filarial infection
Nicolas Pionnier, Julio Furlong-Silva, Stefano A P Colombo, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Toxicon : Official Journal of the International Society on Toxinology
|
October 20, 2025
Complying with ARRIVE 2.0: Reporting essentials for animal models of envenoming therapeutic efficacy testing
Amy E Marriott, Stuart Ainsworth
F1000Research
|
May 6, 2024
Improving <i>in vivo</i> assays in snake venom and antivenom research: A community discussion
Amy E Marriott, Nicholas R Casewell, Elliot Lilley, et al.
Veterinary Parasitology
|
March 4, 2020
Novel anti-Wolbachia drugs, a new approach in the treatment and prevention of veterinary filariasis?
Joseph D Turner, Amy E Marriott, David Hong, et al.
Scientific Reports
|
April 14, 2018
Validation of ultrasound bioimaging to predict worm burden and treatment efficacy in preclinical filariasis drug screening models
Amy E Marriott, Hanna Sjoberg, Hayley Tyrer, et al.
Plos Neglected Tropical Diseases
|
June 7, 2022
A mouse infection model and long-term lymphatic endothelium co-culture system to evaluate drugs against adult Brugia malayi
Amy E Marriott, Julio Furlong Silva, Nicolas Pionnier, et al.
The Journal of Clinical Investigation
|
January 12, 2021
Tetracyclines improve experimental lymphatic filariasis pathology by disrupting interleukin-4 receptor-mediated lymphangiogenesis
Julio Furlong-Silva, Stephen D Cross, Amy E Marriott, et al.
Plos Neglected Tropical Diseases
|
August 4, 2025
Preclinical evaluation of the neutralising efficacy of three antivenoms against the venoms of the recently taxonomically partitioned E. ocellatus and E. romani
Rebecca J Edge, Amy E Marriott, Molly Keen, et al.
Toxicon: X
|
March 24, 2022
<i>In vitro</i> and <i>in vivo</i> preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by <i>Dispholidus typus</i>
Stefanie K Menzies, Rachel H Clare, Chunfang Xie, et al.
Toxicon: X
|
September 16, 2024
Plug and play virus-like particles for the generation of anti-toxin antibodies
Rebecca J Edge, Amy E Marriott, Emma L Stars, et al.
Frontiers in Immunology
|
October 14, 2022
NKp46<sup>+</sup> natural killer cells develop an activated/memory-like phenotype and contribute to innate immunity against experimental filarial infection
Nicolas Pionnier, Julio Furlong-Silva, Stefano A P Colombo, et al.
Page
of 2